AVROBIO, Inc. (AVRO): Price and Financial Metrics
AVROBIO, Inc. (AVRO)
Today's Latest Price: $21.70 USD
0.13 (0.60%)
Updated Jun 4 2:00pm
Add AVRO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
AVRO Daily Price Range
AVRO 52-Week Price Range
AVRO Stock Price Chart More Charts
AVRO Price/Volume Stats
| Current price | $21.70 | 52-week high | $29.32 |
| Prev. close | $21.57 | 52-week low | $9.76 |
| Day low | $21.20 | Volume | 231,402 |
| Day high | $22.31 | Avg. volume | 336,523 |
| 50-day MA | $15.63 | Dividend yield | N/A |
| 200-day MA | $17.47 | Market Cap | 781.96M |
AVROBIO, Inc. (AVRO) Company Bio
AVROBIO, Inc., a clinical stage gene therapy company, focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. It lead product candidate in AVR-RD-01, which is in Phase 1 clinical trial for the treatment of Fabry disease. The company is also developing AVR-RD-02 for the treatment of Gaucher disease; AVR-RD-03 for the treatment of Pompe disease; and AVR-RD-04 for the treatment of cystinosis. The company was founded in 2015 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...